While overall survival (OS) in the high-expression group also showed a trend toward worse outcomes compared to the low-expression group, this difference did not reach statistical significance ( Fig. 2 i).
← all excerpts
Exosome-derived hsa_circ_0007132 promotes lenvatinib resistance by inhibiting the ubiquitin-mediated degradation of NONO.
1
—
—